EDGAR Filing Documents for 0001193125-23-257890

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001193125-23-257890

Filing Date

2023-10-18

Accepted

2023-10-17 19:30:56

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D/A	d547821dsc13da.htm	SC 13D/A	39753
2	EX-99.3	d547821dex993.htm	EX-99.3	30879
	Complete submission text file	0001193125-23-257890.txt		71901

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807

Business Address (908) 947-3120

Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 231330653
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER CA 08807

Business Address

Patel Chintu (Filed by) CIK: 0001737428 (see all company filings)

Type: SC 13D/A